Evidence map›Paper›PMID 16775618›Full record

ArticleGenes and immunity2006

Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus.

P S Ramos, J A Kelly, C Gray-McGuire, G R Bruner, A N Leiran, C M Meyer, B Namjou, K J Espe, W A Ortmann, M Reichlin and 6 more

Registry-linked trialAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00071175 (Lupus Genetic Studies; Lupus Family Registry & Repository), which is not on this map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00071175 completednot on this map

Lupus Genetic Studies; Lupus Family Registry & Repository

TypeobservationalSponsorOklahoma Medical Research FoundationRan1995 to 2013Enrolled3,460ConditionsSystemic Lupus Erythematosus
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 60 citations in OpenAlex.

  1. Towards precision medicine for systemic lupus erythematosus and neuropsychiatric manifestations.Expert review of precision medicine and drug development · 2025
    Article
  2. Article
  3. Systemic lupus erythematosus as a genetic disease.Clinical immunology (Orlando, Fla.) · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. IL-1Journal of immunology research · 2017
    Article
  11. Article
  12. Is preclinical autoimmunity benign?: The case of cardiovascular disease.Rheumatic diseases clinics of North America · 2014
    Review
  13. Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Article
  14. Clinical perspectives on lupus genetics: advances and opportunities.Rheumatic diseases clinics of North America · 2014
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

P S RamosDepartment of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
J A Kelly
C Gray-McGuire
G R Bruner
A N Leiran
C M Meyer
B Namjou
K J Espe
W A Ortmann
M Reichlin
C D Langefeld
J A James
P M Gaffney
T W Behrens
J B Harley
K L Moser
University of Minnesota Medical Center · USOklahoma Medical Research Foundation · USCase Western Reserve University · USWake Forest University · US

Funding

VALIDATING NOVEL GENES IMPLICATED IN LEUKOCYTE CHEMOTAXISP20RR020143 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2004 to 2011
$21.0M
X-LINKED EXTENSION OF THE REVISED HASEMAN-ELSTON ALGORITHM FOR LINKAGE ANALYSISP41RR003655 · NCRR · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI ELSTON, ROBERT C. · 1987 to 2011
$11.5M
HLA GENE COMPLEMENTATION IN PRIMARY SJOGREN'S AND LUPUSR01AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KOTTYAN, LEAH CLAIRE, WEIRAUCH, MATTHEW TYSON · 1987 to 2025
$7.8M
THROMBOCYTOPENIA AND THE GENETICS OF SEVERE LUPUSP50AR048940 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI REICHLIN, MORRIS · 2002 to 2006
$5.8M
GENETIC ASSOCIATION WITH LUPUS IN AMERICAN BLACKSR01AR042460 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 1993 to 2009
$5.1M
Genetic Linkage in LupusR37AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 2005 to 2014
$4.2M
Y RNA SEQUENCES AND RO RNP FUNCTIONR01AI031584 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 1991 to 2006
$2.7M
The first Sm epitopes in lupusR21AI053747 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 2003 to 2004
$464k
GENETICS OF LUPUS-RELATED AUTOIMMUNITY IN HUMANSR03AR046405 · NIAMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MOSER, KATHY L. · 1999 to 2001
$149k
LUPUS MULTIPLEX REGISTRY AND REPOSITORY-264012253N01AR012253 · NIAMS · OKLAHOMA MEDICAL RESEARCH FDN · 2002 to 2005
–
NCRR NIH HHS RR020143NCRR NIH HHS RR03655NIAID NIH HHS AI053747NIAID NIH HHS AI24717NIAID NIH HHS AI31584NIAMS NIH HHS AR048940NIAMS NIH HHS AR42460NIAMS NIH HHS AR46405NIAMS NIH HHS N01 AR12253
6 · The paper itself

Abstract

Autoantibodies are clinically relevant biomarkers for numerous autoimmune disorders. The genetic basis of autoantibody production in systemic lupus erythematosus (SLE) and other autoimmune diseases is poorly understood. In this study, we characterized autoantibody profiles in 1,506 individuals from 229 multiplex SLE pedigrees. There was strong familial aggregation of antinuclear antibodies (ANAs), anti-double-stranded DNA (dsDNA), anti-La/SSB, anti-Ro/SSA, anti-Sm, anti-nRNP (nuclear ribonucleoprotein), IgM antiphospholipid (aPL) antibodies (Abs) and rheumatoid factor (RF) across these families enriched for lupus. We performed genome-wide linkage analyses in an effort to map genes that contribute to the production of the following autoantibodies: Ro/SSA, La/SSB, nRNP, Sm, dsDNA, RF, nuclear and phospholipids. Using an approach to minimize false positives and adjust for multiple comparisons, evidence for linkage was found to anti-La/SSB Abs on chromosome 3q21 (adjusted P=1.9 x 10(-6)), to anti-nRNP and/or anti-Sm Abs on chromosome 3q27 (adjusted P=3.5 x 10(-6)), to anti-Ro/SSA and/or anti-La/SSB Abs on chromosome 4q34-q35 (adjusted P=3.4 x 10(-4)) and to anti-IgM aPL Abs on chromosome 13q14 (adjusted P=2.3 x 10(-4)). These results support the hypothesis that autoantibody production is a genetically complex trait. Identification of the causative alleles will advance our understanding of critical molecular mechanisms that underlie SLE and perhaps other autoimmune diseases.

Indexed as

Genetic LinkagePedigreeAntibodies, AntinuclearAutoantibodiesAutoimmune DiseasesBiomarkersBlack or African AmericanCase-Control StudiesChromosome MappingChromosomes, Human, Pair 13Chromosomes, Human, Pair 3Chromosomes, Human, Pair 4FemaleGenetic Predisposition to DiseaseHumansLupus Erythematosus, SystemicAntibodies, AntinuclearAutoantibodiesBiomarkers

Identifiers

PMID16775618
OpenAlexW2037487383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.